Market leadership Global leader in generic and biosimilar medicines with a broad catalog of approximately 1,300 products and a large patient reach, presenting opportunities to discuss partnerships, formulation diversification, and tender-based procurement with health systems and distributors.

Scale and footprint Extensive workforce and international operations (10001+ employees from 100 nationalities) imply capabilities for large-scale manufacturing, global supply chain collaboration, and regional market entry strategies that can be leveraged for contract manufacturing, licensing, or co-development deals.

Financial health Strong revenue base (over $10B) and substantial funding, indicating capacity for extended sales cycles, larger multi-year contracts, and potential for value-added services such as digital health integrations, pharmacovigilance partnerships, or performance-based collaborations.

Digital readiness Existing tech stack includes analytics, collaboration, and monitoring tools (Qlik, Prometheus, Zoom, Microsoft Intune, etc.), suggesting opportunities to offer integrated compliance, data analytics, or cloud security solutions that align with Sandoz digital transformation and operational efficiency goals.

Sustainability and access Purpose-driven focus on pioneering patient access and substantial social impact offers entry points for partnerships around affordability programs, patient support, or sustainability initiatives that attract health systems and payers seeking cost-effective, patient-centric solutions.